Actinium Pharmaceuticals, Inc. (Delaware) (ATNM): Price and Financial Metrics
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
Today's Latest Price: $0.21 USD
0.01 (5.95%)
Updated Oct 18 6:40pm
Add ATNM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ATNM Daily Price Range
ATNM 52-Week Price Range
ATNM Stock Price Chart More Charts
ATNM Price/Volume Stats
| Current price | $0.21 |
| Prev. close | $0.20 |
| Day low | $0.20 |
| Day high | $0.21 |
| 50-day MA | $0.22 |
| 200-day MA | $0.35 |
| 52-week high | $0.77 |
| 52-week low | $0.19 |
| Volume | 482,200 |
| Avg. volume | 970,853 |
| Dividend yield | N/A |
| Market Cap | 34.11M |
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Company Bio
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The companys targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.
Top Stories View All
Best & Worst Performing Stock Industries for October 18, 2019
Best & Worst Performing Small Cap Stocks for October 18, 2019
Best & Worst Performing Mid Cap Stocks for October 18, 2019
Best & Worst Performing Large Cap Stocks for October 18, 2019
Best & Worst Performing Mega Cap Stocks for October 18, 2019
View All Top Stories
Loading social stream, please wait...